France Menopause Market Size & Outlook, 2022-2030

The menopause market in France is expected to reach a projected revenue of US$ 620.0 million by 2030. A compound annual growth rate of 5.1% is expected of France menopause market from 2023 to 2030.
Revenue, 2022 (US$M)
$417.4
Forecast, 2030 (US$M)
$620.0
CAGR, 2023 - 2030
5.1%
Report Coverage
France

France menopause market highlights

  • The France menopause market generated a revenue of USD 417.4 million in 2022 and is expected to reach USD 620.0 million by 2030.
  • The France market is expected to grow at a CAGR of 5.1% from 2023 to 2030.
  • In terms of segment, dietary supplements was the largest revenue generating treatment in 2022.
  • Dietary Supplements is the most lucrative treatment segment registering the fastest growth during the forecast period.


Menopause market data book summary

Market revenue in 2022USD 417.4 million
Market revenue in 2030USD 620.0 million
Growth rate5.1% (CAGR from 2022 to 2030)
Largest segmentDietary supplements
Fastest growing segmentDietary Supplements
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOTC pharma products, Dietary Supplements
Key market players worldwideBayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis


Other key industry trends

  • In terms of revenue, France accounted for 2.6% of the global menopause market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany menopause market is projected to lead the regional market in terms of revenue in 2030.
  • Spain is the fastest growing regional market in Europe and is projected to reach USD 452.9 million by 2030.

Dietary supplements was the largest segment with a revenue share of 93.22% in 2022. Horizon Databook has segmented the France menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.


France is witnessing a gradual increase in adoption of dietary supplements for various health aspects. Information on the use of food supplements was first collected during the Second Individual and National Study on Food Consumption (INCA), conducted in 2006-07 and later during 2014-2015 for INCA 3. It revealed that the consumption of food supplements almost doubled between the two study periods.

The Directorate-General for Competition, Consumer Affairs and Fraud Control (DGCCRF), in February 2019, released an update regarding vitamin A concentration in dietary supplements for the general population.

However, due to the association of higher concentration of vitamin A with hip fractures and osteoporosis in menopausal women, the change was not permitted for dietary supplements designed for menopausal women. The research-based design of supplements can help deliver desired results, increasing the credibility of products.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Menopause Market Scope

Menopause market segmentation & scope

Menopause Market Companies

Name Profile # Employees HQ Website

France menopause market size, by treatment, 2018-2030 (US$M)

France Menopause Market Outlook Share, 2022 & 2030 (US$M)

France menopause market size, by treatment, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more